|
GTF3C2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.524500E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.914400E-02 |
| Normal-vs-Stage2 |
1.656270E-02 |
| Normal-vs-Stage3 |
1.525730E-02 |
| Normal-vs-Stage4 |
8.375200E-03 |
| Stage1-vs-Stage2 |
2.325400E-01 |
| Stage1-vs-Stage3 |
4.564200E-01 |
| Stage1-vs-Stage4 |
3.389400E-01 |
| Stage2-vs-Stage3 |
5.374600E-01 |
| Stage2-vs-Stage4 |
7.157000E-01 |
| Stage3-vs-Stage4 |
7.755800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.696060E-03 |
| Normal-vs-AfricanAmerican |
2.301600E-01 |
| Normal-vs-Asian |
2.877600E-01 |
| Caucasian-vs-AfricanAmerican |
3.480600E-01 |
| Caucasian-vs-Asian |
6.862700E-03 |
| AfricanAmerican-vs-Asian |
3.362300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.808040E-04 |
| Normal-vs-Female |
3.611800E-01 |
| Male-vs-Female |
7.603800E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.381640E-01 |
| Normal-vs-Age(41-60Yrs) |
1.725980E-02 |
| Normal-vs-Age(61-80Yrs) |
1.222490E-02 |
| Normal-vs-Age(81-100Yrs) |
5.782300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.696200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.752200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.401000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.535000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.431000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.702800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.473800E-01 |
| Normal-vs-Grade 2 |
8.039900E-02 |
| Normal-vs-Grade 3 |
2.123900E-03 |
| Normal-vs-Grade 4 |
7.969900E-04 |
| Grade 1-vs-Grade 2 |
1.024960E-01 |
| Grade 1-vs-Grade 3 |
8.233800E-02 |
| Grade 1-vs-Grade 4 |
2.075700E-02 |
| Grade 2-vs-Grade 3 |
1.153370E-01 |
| Grade 2-vs-Grade 4 |
3.257500E-02 |
| Grade 3-vs-Grade 4 |
4.020400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.087600E-01 |
| Normal-vs-ccB subtype |
5.750100E-04 |
| ccA subtype-vs-ccB subtype |
1.720710E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.117600E-03 |
| Normal-vs-N1 |
4.568000E-01 |
| N0-vs-N1 |
5.870000E-02 |
|
|
